FANCD2 Is a Potential Therapeutic Target and Biomarker in...

Clinical Cancer Research 2014 / 07 Vol. 20; Iss. 14

FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3-FOXO1 Fusion Gene

Singh, M., Leasure, J. M., Chronowski, C., Geier, B., Bondra, K., Duan, W., Hensley, L. A., Villalona-Calero, M., Li, N., Vergis, A. M., Kurmasheva, R. T., Shen, C., Woods, G., Sebastian, N., Fabian,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-0556
Date:
July, 2014
File:
PDF, 1.37 MB
english, 2014
Conversion to is in progress
Conversion to is failed